|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310.60 DKK | +1.32% |
|
+5.11% | -4.50% |
| 02-13 | Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows | RE |
| 02-13 | Novo Nordisk's Wegovy Tablet Reaches 38,000 New Prescriptions in the US | FW |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | DKK 379.36 | +22.14% | 22 | |||||
| Average | 379.36 | +22.14% | 22 | ||||||
| Weighted average by Cap. | 379.36 | +22.14% | 22 |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition